Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa european study (ZEUS)

  1. Wirth, M.
  2. Tammela, T.
  3. Cicalese, V.
  4. Gomez Veiga, F.
  5. Delaere, K.
  6. Miller, K.
  7. Tubaro, A.
  8. Schulze, M.
  9. Debruyne, F.
  10. Huland, H.
  11. Patel, A.
  12. Lecouvet, F.
  13. Caris, C.
  14. Witjes, W.
Revista:
European Urology

ISSN: 1873-7560 0302-2838

Any de publicació: 2015

Volum: 67

Número: 3

Pàgines: 482-491

Tipus: Article

DOI: 10.1016/J.EURURO.2014.02.014 GOOGLE SCHOLAR